TY - JOUR
T1 - Sex-specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes
T2 - The ADVANCE-ON study
AU - Ohkuma, Toshiaki
AU - Peters, Sanne A.E.
AU - Jun, Min
AU - Harrap, Stephen
AU - Cooper, Mark
AU - Hamet, Pavel
AU - Poulter, Neil
AU - Chalmers, John
AU - Woodward, Mark
N1 - Funding Information:
The ADVANCE trial was funded by the grants from the National Health and Medical Research Council (NHMRC) of Australia and Servier. TO is supported by the John Chalmers Clinical Research Fellowship of the George Institute. SAEP is supported by a UK Medical Research Council Skills Development Fellowship (MR/P014550/1). MJ is supported by a Scientia Fellowship from UNSW Sydney. MW is a NHMRC of Australia Principal Research Fellow (1080206).
Funding Information:
TO reports no conflicts of interest. SAEP reports no conflicts of interest. MJ reports receiving grant support from the National Health and Medical Research Council of Australia (Project Grant: 1148060) and unrestricted grant support from VentureWise (a wholly owned commercial subsidiary of NPS MedicineWise) to conduct a commissioned project funded by AstraZeneca. SH reports grants from the George Institute for Global Health during the conduct of the study; and from Servier, outside the submitted work. MC reports grants from Novo Nordisk, grants and personal fees from Boehringer Ingelheim, and personal fees from Servier, AstraZeneca, Novartis, Merck and Bayer, outside the submitted work. PH reports consulting fees from Servier, and grant support from Quebec CQDM and Servier. NP received honoraria and personal fees from Servier Laboratories, Takeda Pharmaceutical Company, Menarini Group and Pfizer, and grant support from Servier Laboratories and Pfizer. JC received research grants from the National Health and Medical Research Council of Australia and from Servier for the ADVANCE trial and ADVANCE‐ON post‐trial follow‐up, and honoraria for speaking about these studies at scientific meetings, and reports grant support from Program Grant APP1149987 from the National Health and Medical Research Council of Australia. MW reports consultancy fees from Amgen and Kirin and is supported by an Australian National Health and Medical Research Council fellowship (APP1080206) and Program Grant (APP1149987).
Funding Information:
The ADVANCE trial was funded by the grants from the National Health and Medical Research Council (NHMRC) of Australia and Servier. TO is supported by the John Chalmers Clinical Research Fellowship of the George Institute. SAEP is supported by a UK Medical Research Council Skills Development Fellowship (MR/P014550/1). MJ is supported by a Scientia Fellowship from UNSW Sydney. MW is a NHMRC of Australia Principal Research Fellow (1080206).
Publisher Copyright:
© 2020 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Aim: To examine possible sex differences in the excess risk of myocardial infarction (MI) consequent to a range of conventional risk factors in a large-scale international cohort of patients with diabetes, and to quantify these potential differences both on the relative and absolute scales. Materials and methods: Eleven thousand and sixty-five participants (42% women) with type 2 diabetes in the ADVANCE trial and its post-trial follow-up study, ADVANCE-ON, were included. Cox regression models were used to estimate hazard ratios (HRs) for associations between risk factors and MI (fatal and non-fatal) by sex, and the women-to-men ratio of HRs (RHR). Results: Over a median of 9.6 years of follow-up, 719 patients experienced MI. Smoking status, smoking intensity, higher systolic blood pressure (SBP), HbA1c, total and LDL cholesterol, duration of diabetes, triglycerides, body mass index (BMI) and lower HDL cholesterol were associated with an increased risk of MI in both sexes. Furthermore, some variables were associated with a greater relative risk of MI in women than men: RHRs were 1.75 (95% CI: 1.05-2.91) for current smoking, 1.53 (1.00-2.32) for former smoking, 1.18 (1.02-1.37) for SBP, and 1.13 (95% CI, 1.003-1.26) for duration of diabetes. Although incidence rates of MI were higher in men (9.3 per 1000 person-years) compared with women (5.8 per 1000 person-years), rate differences associated with risk factors were greater in women than men, except for HDL cholesterol and BMI. Conclusions: In patients with type 2 diabetes, smoking, higher SBP and longer duration of diabetes had a greater relative and absolute effect in women than men, highlighting the importance of routine sex-specific approaches and early interventions in women with diabetes.
AB - Aim: To examine possible sex differences in the excess risk of myocardial infarction (MI) consequent to a range of conventional risk factors in a large-scale international cohort of patients with diabetes, and to quantify these potential differences both on the relative and absolute scales. Materials and methods: Eleven thousand and sixty-five participants (42% women) with type 2 diabetes in the ADVANCE trial and its post-trial follow-up study, ADVANCE-ON, were included. Cox regression models were used to estimate hazard ratios (HRs) for associations between risk factors and MI (fatal and non-fatal) by sex, and the women-to-men ratio of HRs (RHR). Results: Over a median of 9.6 years of follow-up, 719 patients experienced MI. Smoking status, smoking intensity, higher systolic blood pressure (SBP), HbA1c, total and LDL cholesterol, duration of diabetes, triglycerides, body mass index (BMI) and lower HDL cholesterol were associated with an increased risk of MI in both sexes. Furthermore, some variables were associated with a greater relative risk of MI in women than men: RHRs were 1.75 (95% CI: 1.05-2.91) for current smoking, 1.53 (1.00-2.32) for former smoking, 1.18 (1.02-1.37) for SBP, and 1.13 (95% CI, 1.003-1.26) for duration of diabetes. Although incidence rates of MI were higher in men (9.3 per 1000 person-years) compared with women (5.8 per 1000 person-years), rate differences associated with risk factors were greater in women than men, except for HDL cholesterol and BMI. Conclusions: In patients with type 2 diabetes, smoking, higher SBP and longer duration of diabetes had a greater relative and absolute effect in women than men, highlighting the importance of routine sex-specific approaches and early interventions in women with diabetes.
UR - http://www.scopus.com/inward/record.url?scp=85087152132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087152132&partnerID=8YFLogxK
U2 - 10.1111/dom.14103
DO - 10.1111/dom.14103
M3 - Article
C2 - 32476250
AN - SCOPUS:85087152132
SN - 1462-8902
VL - 22
SP - 1818
EP - 1826
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
IS - 10
ER -